Evidence map›Paper›PMID 22202674›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.

Huali Zhang, Pattraranee Limphong, Joel Pieper, Qiang Liu, Christopher K Rodesch, Elisabeth Christians, Ivor J Benjamin

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 192 citations in OpenAlex.

  1. Trial
  2. Article
  3. Over-Intake of Plant-Derived Antioxidants, HInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Neutrophil redox imbalance in acute coronary syndrome.Journal of medical biochemistry · 2026
    Article
  7. Reductive stress in cancer immunology and targeted therapy.Acta biochimica et biophysica Sinica · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Does the Type of Semen Affect the Phosphoproteome of Turkey (International journal of molecular sciences · 2025
    Article
  18. Review
  19. Review
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huali ZhangLaboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
Pattraranee Limphong
Joel Pieper
Qiang Liu
Christopher K Rodesch
Elisabeth Christians
Ivor J Benjamin
University of Utah · US

Funding

Protein Misfolding Diseases and Oxido-Reductive PathwaysDP1OD006438 · OD · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2009 to 2011
$2.2M
Reductive Stress in the Pathogenesis of R120GCryAB CardiomyopathyR01HL063834 · NHLBI · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2000 to 2010
$2.2M
Mechanisms of HSPB2 in Cardiac Metabolism and Ischemic CardioprotectionR01HL074370 · NHLBI · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2008 to 2011
$1.5M
Protein Misfolding Diseases and Oxido-Reductive PathwaysDP1HL117650 · NHLBI · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2012 to 2013
$1.5M
NHLBI NIH HHS 1R01HL66701NHLBI NIH HHS 2 R01 HL063834-06NHLBI NIH HHS 5R01HL074370-03NHLBI NIH HHS DP1 HL117650NHLBI NIH HHS R01 HL063834NHLBI NIH HHS R01 HL074370NIH HHS 5DP1OD006438-02NIH HHS DP1 OD006438
6 · The paper itself

Abstract

To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss- and gain-of-function GSH content in vitro. We monitored the redox events in the cytosol and mitochondria using reduction-oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H(2)O(2) or the Trx reductase inhibitor 1-chloro-2,4-dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, E(hc) (GSSG/2GSH), respectively. In contrast, N-acetyl-L-cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3- to 4-fold increase of GSH and caused 7 or 12 mV more reducing E(hc), respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC(50) 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.

Indexed as

Oxidation-ReductionOxidative StressAcetylcysteineAnimalsCytosolDinitrochlorobenzeneFree Radical ScavengersGlutamate-Cysteine LigaseGlutathioneGlutathione DisulfideGreen Fluorescent ProteinsHeartHEK293 CellsHomeostasisHumansHydrogen PeroxideAcetylcysteineDinitrochlorobenzeneFree Radical ScavengersGlutamate-Cysteine LigaseGlutathioneGlutathione DisulfideGreen Fluorescent ProteinsHydrogen PeroxideIndicators and ReagentsOxidantsProtein SubunitsReactive Oxygen SpeciesThioredoxins

Identifiers

PMID22202674
PMCPMC3316899
OpenAlexW2076361659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.